Congenital heart defects and biomarkers of methylation in children: a case-control study

Sylvia A Obermann-Borst1, Lydi M J W van Driel, Willem A Helbing

  • 1Department of Obstetrics and Gynaecology/Division of Obstetrics and Prenatal Medicine, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands.

Insights

Maternal methylation pathway derangements are linked to congenital heart defects (CHD). Studies show higher methylation biomarkers in children with complex CHD, suggesting a potential link to global hypomethylation, especially in Down syndrome cases.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Maternal methylation pathway disruptions, including hypomethylation and hyperhomocysteinemia, are associated with congenital heart defect (CHD) risk.
  • The role of periconception exposure to these metabolic issues in fetal chromosome segregation and metabolic programming remains unclear.

Purpose of the Study:

  • To investigate the association between maternal methylation pathway biomarkers and CHD in offspring.
  • To explore potential differences in methylation status between children with and without CHD, including specific subtypes like Down syndrome.

Main Methods:

  • A Dutch population-based case-control study involving 143 children with CHD and 186 controls.
  • Analysis of S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH), total homocysteine (tHcy), folate, vitamin B12, and MTHFR gene polymorphisms.
  • Statistical comparisons between cases and controls, adjusting for relevant covariates.

Main Results:

  • Children with CHD exhibited significantly higher median concentrations of SAM and folate compared to controls.
  • Complex CHD cases showed elevated SAM, SAH, and serum folate, independent of MTHFR polymorphisms.
  • Children with Down syndrome and CHD displayed higher SAH and a lower SAM:SAH ratio, indicating potential global hypomethylation.

Conclusions:

  • Elevated methylation biomarker concentrations in young children correlate with complex CHD.
  • A global hypomethylation status may be linked to CHD, particularly in Down syndrome, warranting further investigation in specific tissues and DNA methylation levels.
Abstract